Duquesne
WVE · Medicine & biotech

Wave Life Sciences

Develops RNA medicines for obesity and rare genetic diseases.
No change
Duquesne owns 173,000 shares of Wave Life Sciences, worth about $1 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
173,000
Jun 30
173,000

The numbers

Shares they own
173,000
Value on Jun 30, 2026
$1,005,000
about $1 million
Share of their money
0.0%
less than $1 of every $100 · 85th of 85
Price per share on Jun 30
$5.81
Kind
Shares
Also owned by
No other fund we follow
More about Wave Life Sciences
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works